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INTRODUCTION
Congenital heart disease occurs in about 0.7% of newborn
infants worldwide, and more than 85% of these infants can
expect to survive into adulthood due to recent advances in
pediatric cardiology and cardiac surgery (1, 2). Consequent-
ly, the number of women with congenital heart disease who
reach childbearing age is increasing, and many of them con-
template pregnancy. Although some women with congeni-
tal heart disease cannot tolerate the hemodynamic changes
associated with pregnancy, many have sufficient cardiac reserve
to carry pregnancy to term. Recently, a number of studies
have evaluated therapeutic and management strategies for
pregnancy and delivery in patients with congenital heart
disease (3-6). However, a number of problems remain, and
such strategies are often based on comprehensive clinical
assessments without clear data due to the non-availability of
standardized management strategies and limited scientific
evidence. Therefore, currently, it is often impossible to pro-
vide evidence-based recommendations about the risk of preg-
nancy or to optimize the management of pregnant patients
with congenital heart disease. 
Pregnancy in women with congenital heart disease carries
a considerable risk to both mothers and neonates, although
prognoses continue to improve (7-10). Nevertheless, no report
has been issued on the outcomes of pregnant patients with
congenital heart disease in Korea, and thus, there is a need
to define a risk stratification scheme for women with con-
genital heart disease to ensure appropriate obstetric counsel-
ing and care. The purpose of this study was to assess the out-
comes and to identify the risk factors of adverse maternal and
neonatal events in pregnant women with congenital heart
disease in a tertiary care setting. 
MATERIALS AND METHODS
Study subjects 
The records of all 890 female patients with congenital
heart disease registered at the Grown-Up Congenital Heart
Disease (GUCH) clinic at our hospital between September
1995 and April 2006 were reviewed. Of these 890 patients,
38 became pregnant, and 4 of these 38 patients with acquired
and congenital heart disease were excluded. Finally, the out-
comes of 49 pregnancies in 34 patients with congenital heart
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Outcomes of Pregnancy in Women with Congenital Heart Disease: 
A Single Center Experience in Korea
Pregnancy outcomes in patients with congenital heart disease have not been fully
assessed in Korea. Forty-nine pregnancies that occurred in 34 women with con-
genital heart disease who registered at our hospital between September 1995 and
April 2006 were reviewed. Spontaneous abortions occurred in two pregnancies at
6
+1 and 7 weeks, and another two underwent elective pregnancy termination. One
maternal death in puerperium occurred in a woman with Eisenmenger syndrome.
Maternal cardiac complications were noted in 18.4%, pulmonary edema in 16.3%,
symptomatic arrhythmia in 6.1%, deterioration of New York Heart Association (NYHA)
functional class by ≥ ≥2 in 2.0%, and cardiac death in 2.0%. Independent predic-
tors of adverse maternal cardiac events were an NYHA functional class of ≥ ≥3 (odds
ratio [OR], 20.3), right ventricular dilation (OR, 21.2), and pulmonary hypertension
(OR, 21.8). Neonatal complications occurred in 22.4% of pregnancies and included
preterm delivery (16.3%), small for gestational age (12.2%), and neonatal death
(2.0%). Independent predictors of adverse neonatal events were pulmonary hyper-
tension (OR, 6.8) and NYHA functional class ≥ ≥3 (OR, 23.0). Pregnancy in women
with congenital heart disease was found to be significantly associated with mater-
nal cardiac and neonatal complications. Pre-pregnancy counseling and multidisci-
plinary care involving cardiologists and obstetricians are recommended for women
with congenital heart disease contemplating pregnancy.
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disease were analyzed.
Initial data were obtained before pregnancy or at first pre-
natal visit. Variables included maternal age, gestational age,
parity status, New York Heart Association (NYHA) func-
tional class, nature of the underlying cardiac lesion, cardiac
medications, prior surgery/interventions, comorbid condi-
tions (diabetes, pulmonary disease, systemic and/or pulmonary
thromboembolic disease), prior cardiac events (heart failure,
infective endocarditis, and arrhythmia), oxygen saturation,
laboratory values (blood urea nitrogen, creatinine, and hema-
tocrit), electrocardiography, and a comprehensive echocar-
diographic assessment. 
Follow-up data were collected from outpatient clinics
throughout pregnancy and puerperium. Fetal echocardiog-
raphy was performed in all patients, and pediatric echocar-
diography was performed on all infants with an abnormal
physical examination. Complete data on cardiac, obstetric,
and neonatal events were available for all 49 pregnancies.
Definitions
Cardiac, obstetric, and neonatal events were classified
according to previously proposed definitions determined by
Siu and colleagues (5). Maternal cardiac events were defined
as cardiac death, symptomatic arrhythmia, deterioration of
NYHA functional class by ≥2, or pulmonary edema docu-
mented by chest radiography. Neonatal events were defined
as preterm delivery (<37 weeks of gestation), small birth
weight for gestational age (<10th percentile), fetal death
(≥20 weeks of gestation), or neonatal death (within the
first month after birth). Spontaneous abortion was defined
as fetal loss before 20 weeks of gestation. Obstetric events
were defined as pregnancy-induced hypertension, postpar-
tum hemorrhage, and noncardiac death. 
Left ventricular (LV) systolic dysfunction was defined as
an ejection fraction of ≤40% by Simpson’s rule, has been
widely used to predict pregnancy-related maternal cardiac
outcomes (5, 10), and right ventricular (RV) dilation was
defined as a mid right ventricular diameter at end diastole
of ≥38 mm (11). Pulmonary hypertension was defined as
an estimated systolic pulmonary artery pressure (sPAP) of
>40 mmHg as determined by echocardiography (12). The
identification of a tricuspid regurgitation jet and the quan-
tification of its velocity (v) allow pulmonary artery pressure
to be estimated using the equation sPAP=4v2+assumed
right atrial pressure (RAP). RAP values were estimated as
follows: lack of inferior vena cava (IVC) dilatation and pletho-
ra=10 mmHg, either IVC dilatation or plethora=15 mmHg,
and IVC dilatation and plethora=20 mmHg. 
Statistical analysis
SAS Version 8 (SAS Institute) software was used for the
statistical analysis. Continuous data were expressed as means
±standard deviations and categorical data as percentages.
Maternal cardiac, neonatal, and obstetric events were ana-
lyzed separately, and because some women became pregnant
twice or more, collected pregnancy data was regarded as non-
independent data. Generalized estimating equations, as pro-
posed by Zeger and Liang (13), were used to construct regres-
sion marginal models to produce cluster-sampling data. Uni-
variate and multivariate predictors of maternal cardiac, neona-
tal, and obstetric events were assessed. pvalues of <0.05 were
considered statistically significant.
RESULTS
Baseline characteristics of the study population 
A total of 34 women of mean age 29.8±3.6 yr became
pregnant 49 times: 21 patients had one pregnancy, 11 had
two, and 2 had three. The baseline characteristics of the study
population are presented in Table 1. Of these 34 women, 6
Demographics
Maternal age (yr) 29.8±3.6
Parity status
0 20 (40.8%)
1 13 (26.5%)
≥2 16 (32.7%)
C-section 25 (51.0%)
Clinical examination
Oxygen saturation (%) 96.1±6.8%
Oxygen saturation ≤90% 6 (12.2%)
NYHA functional class
Class 1-2 43 (87.8%)
Class 3-4 6 (12.2%)
Past medical history
Congestive heart failure 4 (8.2%)
Infective endocarditis 4 (8.2%)
Symptomatic arrhythmia 3 (6.1%)
Cerebrovascular accident 2 (4.1%)
Hypertension 2 (4.1%)
Echocardiographic findings
Moderate or severe mitral regurgitation 0 (0%)
Moderate or severe tricuspid regurgitation 13 (26.5%)
Moderate or severe aortic regurgitation 7 (14.3%)
Moderate or severe pulmonary regurgitation 4 (8.2%)
Pulmonary stenosis 9 (18.4%)
Pulmonary hypertension 8 (14.5%)
Medication
Antiplatelet agents  5 (10.2%)
Digoxin 5 (10.2%)
Diuretics 4 (8.2%)
Angiotensin-converting enzyme inhibitors 3 (6.1%)
Warfarin 3 (6.1%)
Antiarrhythmics 2 (4.1%)
Table 1. Baseline maternal characteristics in 49 pregnancies
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had cyanosis defined as an initial oxygen saturation of ≤90%
and an NYHA functional class of ≥3 at initial visits. These
6 cyanotic patients had either unrepaired congenital heart
disease or a repaired tetralogy of Fallot (TOF) with major
aortopulmonary collateral artery syndrome, and their initial
oxygen saturations ranged from 70% to 86%. These patients
were transferred from local clinics at near term. Cardiovas-
cular medication was taken in 9 patients before pregnancy,
and all medications were stopped at diagnosis of pregnancy,
except for digoxin in two cases and aspirin in one. 
Underlying congenital heart lesions are summarized in
Table 2. Congenital cardiac lesions were diagnosed before
pregnancy in 40 pregnancies (81.6%), in 28 patients (82.4
%). In the remaining 6 patients, diagnoses were made dur-
ing pregnancy or after delivery. These patients had the fol-
lowing cardiac malformations: atrial septal defect (n=3),
patent ductus arteriosus (n=1), double outlet right ventricle
with a subaortic ventricular septal defect (n=1), and Ebstein’s
anomaly (n=1). Surgical or interventional procedures were
performed before pregnancy in 25 pregnancies (51.0%) in
17 patients (50.0%). Cardiology counseling before pregnancy
was performed in 20 pregnancies (40.8%) in 14 patients
(41.2%).
Clinical and echocardiographic data during pregnancies
are shown in Table 3. One patient had Eisenmenger syn-
drome. This patient, who had a double outlet right ventri-
cle with a subaortic ventricular septal defect, did not receive
cardiology counseling before pregnancy and refused a rec-
ommendation for the therapeutic abortion. 
Maternal cardiac events
Maternal cardiac events occurred in 9 completed pregnan-
cies (18.4%), and included heart failure with pulmonary
edema, cardiac arrhythmia, a decline in NYHA class of ≥
2, and cardiac death (Table 4, 5). The most common adverse
cardiac event was pulmonary edema, which was document-
ed in 8 pregnancies, and the underlying congenital cardiac
anomalies were unoperated atrial septal defect (n=5), unop-
erated patent ductus arteriosus (n=1), repaired TOF (n=1),
and unoperated double outlet right ventricle with subaortic
ventricular septal defect (n=1). Symptomatic tachyarrhyth-
mias were documented in 3 patients. Two of them with
Ebstein’s anomaly were cardioverted for atrial flutter/fibril-
lation, and one patient with repaired TOF was successfully
treated medically for supraventricular tachycardia. One mater-
nal death occurred in puerperium in a woman with Eisen-
menger syndrome. There was no association between the
mode of delivery and the maternal cardiac event rate: 12.5%
Shunt lesion 25 (70.8%) 32 (65.3%)
Atrial septal defect 15 (44.1%) 22 (44.9%)
Unoperated 9 (26.5%) 14 (28.6%)
Surgically repaired 6 (17.6%) 9 (18.4%)
Ventricular septal defect 9 (26.5%) 10 (20.4%)
Unoperated 6 (17.6%) 6 (12.2%)
Surgically repaired 3 (8.8%) 4 (8.2%)
Patent ductus arteriosus 1 (2.9%) 2 (4.1%)
Right-sided obstructive lesion 3 (8.8%) 5 (10.2%)
Unoperated pulmonary stenosis 1 (2.9%) 1 (2.0%)
Surgically corrected pulmonary 
stenosis 1 (2.9%) 2 (4.1%)
PAVSD and RV-PA conduit* 1 (2.9%) 2 (4.1%)
Left-sided obstructive lesion  0 (0%) 0 (0%)
Surgically repaired tetralogy of Fallot 3 (8.8%) 5 (10.2%)
Ebstein’s anomaly 3 (8.8%) 4 (8.2%)
Table 2. Types of cardiac lesions
*PAVSD and RV-PA conduit indicates pulmonary atresia, ventricular
septal defect, and right ventricle to pulmonary artery conduit.
PAVSD, partial atrioventricular septal defect; RV-PA, right ventricle to
pulmonary artery.
Congenital lesion
Patients 
(n=34)
Pregnancies 
(n=49)
Congenital cardiac lesions
(n=49)
NYHA Fc ≥3 
(n=7)
Pulmonary 
hypertension (n=8)
LV systolic 
dysfunction* (n=5)
RV dilatation
�
(n=7)
Unoperated ASD (n=14) 2 (4.1%) 7 (14.3%) 3 (6.1%) 4 (8.2%)
Surgically repaired ASD (n=9) 0 0 0 0
Unoperated VSD (n=6) 2 (4.1%) 1 (2.0%) 1 (2.0%) 0
Surgically repaired VSD (n=4) 0 0 0 0
Patent ductus arteriosus (n=2) 0 0 0 0
Unoperated pulmonary stenosis (n=1) 0 0 0 0
Surgically corrected pulmonary stenosis (n=2) 0 0 1 (2.0%) 0
PAVSD and RV-PA conduit (n=2) 0 0 0 0
Surgically repaired tetralogy of Fallot (n=5) 3 (6.1%) 0 0 1 (2.0%)
Ebstein’s anomaly (n=4) 0 0 0 2 (4.1%)
Table 3. Clinical and echocardiographic data during pregnancies
*Left ventricular systolic dysfunction was defined as an ejection fraction of ≤40% by Simpson’s rule; 
� Right ventricular dilatation was defined as a
mid right ventricular diameter ≥38 mm at end diastole.
NYHA Fc, New York Heart Association functional class; LV, left ventricle; RV, right ventricle; ASD, atrial septal defect; VSD, ventricular septal defect;
PAVSD, partial atrioventricular septal defect; RV-PA, right ventricle to pulmonary artery.Pregnancy Outcomes in Congenital Heart Disease Patients 811
for vaginal delivery vs. 24.0% for cesarean section (p=0.46). 
Univariate and multivariate predictors of maternal car-
diac events are summarized in Table 6. An NYHA function-
al class of ≥3, pulmonary hypertension, and RV dilation
were identified as independent predictors of an adverse mater-
nal cardiac event.
Obstetric and neonatal events
Four pregnancies (8.2%) were aborted; 2 (4.1%) sponta-
neously and 2 (4.1%) electively. The two spontaneous abor-
tions occurred during the first trimester; after 6+1 and 7 weeks
of gestation. Cesarean section was performed in 25 pregnan-
cies (51.0%), and 20 (40.8%) pregnancies resulted in suc-
cessful vaginal deliveries. The 24 cesarean sections (96.0%)
were performed due to obstetric indications. Pregnancy-
induced hypertension complicated 3 pregnancies (6.1%),
and postpartum hemorrhage complicated 3 (6.1%). All
ongoing 45 pregnancies were singletons. 
Obstetric and neonatal events are shown in Table 4, and
stratified by congenital cardiac lesions in Table 5. Neonatal
events occurred in 11 pregnancies (22.4%), and preterm deliv-
ery and small for gestational age were the most common.
The mean gestation period at delivery was 38.3±2.2 weeks.
Of the 45 live births, 5 neonates (11.1%) had an Apgar score
of ≤5/10 at 1 min, but no adverse neonatal event occurred
among these 5. The only neonatal death occurred in a patient
with an unoperated ventricular septal defect. This pregnan-
Aborted pregnancy 4 (8.2)
Spontaneous 2 (4.1)
Induced 2 (4.1)
Congenital cardiac anomaly of fetus 4 (8.2)
Maternal cardiac event 9 (18.4)
Pulmonary edema 8 (16.3)
Symptomatic tachyarrhythmia 4 (8.2)
Decline in NYHA functional class by ≥2 1 (2.0)
Cardiac death 1 (2.0)
Obstetric event 5 (10.2)
Pregnancy-induced hypertension 3 (6.1)
Postpartum hemorrhage 3 (6.1)
Neonatal event 11 (22.4)
Preterm delivery 8 (16.3)
Small for gestational age 6 (12.2)
Neonatal death 1 (2.0)
Table 4. Cardiac, obstetric, and neonatal outcomes 
Number (%) 
of pregnancies
Congenital cardiac lesions
(n=49)
Cardiac outcomes
(n=9)
Obstetric outcomes
(n=5)
Neonatal outcomes
(n=11)
Abortion
(n=4)
Unoperated ASD (n=14) 5 (10.2%) 2 (4.1%) 4 (8.2%) 0
Surgically repaired ASD (n=9) 0 0 0 1 (2.0%)
Unoperated VSD (n=6) 1 (2.0%) 0 1 (2.0%) 0
Surgically repaired VSD (n=4) 0 0 3 (6.1%) 0
Patent ductus arteriosus (n=2) 1 (2.0%) 2 (4.1%) 1 (2.0%) 0
Unoperated pulmonary stenosis (n=1) 0 0 0 0
Surgically corrected pulmonary stenosis (n=2)  0 0 0 1 (2.0%)
PAVSD and RV-PA conduit (n=2) 0 0 0 0
Surgically repaired tetralogy of Fallot (n=5) 2 (4.1%) 1 (2.0%) 2 (4.1%) 1 (2.0%)
Ebstein’s anomaly (n=4) 0 0 0 1 (2.0%)
Table 5. Cardiac, obstetric, and neonatal outcomes by congenital cardiac lesions
OR, odds ratio; CI, confidence interval; NYHA, New York Heart Associ-
ation; RV, right ventricle; LVEF, left ventricular ejection fraction. 
OR 95% CI p value
Univariate predictor
NYHA functional class ≥3 15.2 2.2-105.4 0.007
Prior cardiac events 19.5 1.7-219.5 0.016
Pulmonary hypertension 38.0 5.2-276.8 <0.001
LVEF ≤40% 31.2 2.9-337.4 0.003
RV dilation 23.8 3.4-164.7 0.001
Multivariate predictor
Pulmonary hypertension 21.8 1.2-410.3 0.040
NYHA functional class ≥3 20.3 1.0-425.8 0.050
RV dilation 21.2 1.1-412.5 0.044
Table 6. Univariate and multivariate predictors of maternal car-
diac events
OR 95% CI p value
Univariate predictor
NYHA functional class ≥3 30.8 3.0-311.8 0.001
Prior cardiac events 13.9 1.3-151.2 0.031
LVEF ≤40% 6.8 1.0-47.3 0.053
Pulmonary hypertension 9.7 1.8-51.8 0.009
Multivariate predictor
Pulmonary hypertension 6.8 1.0-46.9 0.050
NYHA functional class ≥3 23.0 2.0-261.1 0.011
Table 7. Univariate and multivariate predictors of neonatal events
ASD, atrial septal defect; VSD, ventricular septal defect; PAVSD, partial atrioventricular septal defect; RV-PA, right ventricle to pulmonary artery.
NYHA, New York Heart Association.
OR, odds ratio; CI, confidence interval; NYHA, New York Heart Associ-
ation; LVEF, left ventricular ejection fraction.812 Y.B. Song, S.W. Park, J.H. Kim, et al.
cy was complicated by infective endocarditis requiring hos-
pitalization and antibiotics. The neonate expired 10 days
after delivery due to complications arising from prematuri-
ty. Univariate and multivariate predictors of neonatal events
are summarized in Table 7. Pulmonary hypertension and an
NYHA functional class of ≥3 were found to be indepen-
dent predictors of an adverse neonatal event.
Among the 45 live births, the rate of congenital heart dis-
ease was 8.9%. The following cardiac malformations were
diagnosed: atrial septal defect (n=1), ventricular septal defect
(n=1), coarctation of aorta with ventricular septal defect (n=
1), and pulmonary stenosis with a hypoplastic right ventri-
cle (n=1). All cases were detected by fetal echocardiography
before birth.
DISCUSSION
The problems posed by congenital heart disease in adults
are growing rapidly, in terms of both the numbers affected
and disease complexity, due to the remarkable diagnostic and
therapeutic advances made over the recent years (6). Thus,
pregnancy outcomes and related risks in this heterogeneous
patient population require comprehensive assessment to facil-
itate adequate patient counseling regarding safety issues and
antenatal care planning. In the current study, we report the
experience of a single center in terms of pregnancy outcomes
in women with congenital heart disease. 
The maternal cardiac event rate determined in the pre-
sent study (18.4%) is comparable to that reported in a recent
cohort study (19.4%) of pregnant women with congenital
heart disease only (10). In a large cohort of pregnant women
with heart disease, Avila et al. reported a maternal cardiac
event rate of 23.5% (14). Its higher event rate may be explain-
ed by difference of study population, where only 19% of their
patients had congenital heart disease.
In accordance with previous studies (5, 14), the most com-
mon maternal cardiac event in our study was pulmonary
edema with congestive heart failure, which was followed by
symptomatic tachyarrhythmia. All pulmonary edema and
symptomatic tachyarrhythmia events responded to medical
treatment. In 25 pregnancies (51.0%), patients underwent
a surgical or interventional procedure before pregnancy, and
a trend toward a favorable cardiac outcome was observed in
this group, although there was no statistical significance
(8.0% vs. 29.2%, p=0.07). Cardiology counseling before
pregnancy was performed in 20 pregnancies (40.8%), and
this too showed a tendency toward a lower adverse maternal
cardiac event rate (5.0% vs. 27.6%, p=0.06). Postulated
reasons for the lower incidence of pre-pregnancy cardiologic
counseling include unplanned pregnancy and lack of educa-
tion for risk of pregnancy. 
In the present study, an NYHA functional class of ≥3,
pulmonary hypertension, and RV dilatation were identified
as independent predictors of an adverse maternal cardiac
event, which concurs with previous reports on the topic (15,
16). In a recent cohort study, Khairy et al. found that women
with a low subpulmonary ventricular ejection fraction and/or
severe pulmonary regurgitation are 9 times more likely to
develop adverse maternal cardiac events during pregnancy
(10). 
The adverse neonatal event rate of 22.4% observed in this
study is comparable to the 27.8% found in a large cohort of
pregnant women with congenital heart disease, and as was
found in our study, the most common neonatal complica-
tions were premature birth followed by small for gestational
age (5, 10). 
Our study showed that pulmonary hypertension and an
NYHA functional class of ≥3 were found to be indepen-
dent predictors of an adverse neonatal event. A poor NYHA
functional class has been previously reported to be a risk fac-
tor of neonatal events (5, 17). However, our study failed to
substantiate the previously reported predictive role of mater-
nal left heart obstruction on neonatal outcome (5, 17), due
to the lack of patients with a left-sided obstructive lesion.
The congenital heart disease rate (8.9%) among 45 live
births found in the present study, is consistent with those
previously reported in women with a congenital cardiac
anomaly (5, 10), and is approximately 10-fold higher than
that found in the general population (18).
This study had several limitations that require considera-
tion. First, the number of patients enrolled was relatively
small, and therefore, its statistical power in terms of identi-
fying predictors of cardiac and neonatal events is limited.
Second, due to its retrospective nature, some echocardio-
graphic data was unavailable, and treatment strategies and
outcomes assessment were not standardized. Finally, because
this study was performed at a tertiary care center, the study
cohort might show selection bias. However, pregnant patients
with congenital heart disease are usually transferred to tertiary
care centers, and thus, we believe that our findings reflect
the real world.  
Based on our findings, maternal cardiac and neonatal com-
plications are considerable among women with congenital
heart disease. Therefore, we recommend that pre-pregnancy
counseling and multidisciplinary care involving cardiolo-
gists, pediatricians, and obstetricians should be adopted when
women with congenital heart disease are considering preg-
nancy. Furthermore, prospective, multicenter studies are
needed to confirm our findings and to establish evidence-
based guidelines concerning the management of pregnant
patients with congenital heart disease in Korea.
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